Clinical Trial

Safety and Efficacy of Intensified Chemotherapy Regimens in Aggressive B-cell Lymphomas With MYC Rearrangement

Study acronym: OSR-CARMEN
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
A multicenter, retrospective, observational drug study using anonymized data from adult patients with aggressive B-cell lymphoma treated with the CARMEN regimen. The data were collected during normal clinical practice, therefore neither diagnostic approaches nor experimental drugs/devices will be applied.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-16.
Trial Details
NCT Number NCT07663175
Lead Sponsor IRCCS San Raffaele
Conditions B-cell Lymphomas With MYC Rearrangement
Enrollment 500 participants
Start Date 2022-11-01
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-26